Related Experiment Video
Updated: Jun 3, 2025

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
Respiratory Syncytial Virus: A WAidid Consensus Document on New Preventive Options
Matteo Riccò1, Bahaa Abu-Raya2,3,4, Giancarlo Icardi5,6
1Servizio di Prevenzione e Sicurezza Negli Ambienti di Lavoro (SPSAL), AUSL-IRCCS di Reggio Emilia, Via Amendola 2, 42122 Reggio Emilia, Italy.
New long-acting monoclonal antibodies and vaccines offer effective Respiratory Syncytial Virus (RSV) prevention for infants and older adults. These advancements significantly reduce severe RSV-related lower respiratory tract infections and hospitalizations.
Area of Science:
- Immunology
- Infectious Diseases
- Public Health
Background:
- Respiratory Syncytial Virus (RSV) is a major cause of respiratory illness, especially in vulnerable populations like infants and the elderly.
- Current prevention options for RSV were historically limited, often requiring multiple doses or offering less comprehensive protection.
Purpose of the Study:
- To review recent breakthroughs in RSV prevention strategies.
- To highlight the efficacy of novel monoclonal antibodies and vaccines against RSV.
Main Methods:
- Consensus development by an international expert group from the World Association of Infectious Diseases and Immunological Disorders (WAidid).
- Review of recent clinical trial data and advancements in RSV immunoprophylaxis and vaccination.
Main Results:
- Long-acting monoclonal antibodies, such as nirsevimab, provide season-long RSV protection with a single dose, significantly reducing infant hospitalizations.
- New vaccines (e.g., RSVpreF, RSVpreF3) demonstrate high efficacy in preventing RSV-related lower respiratory tract infections in older adults.
- Maternal vaccination strategies show potential for protecting newborns during their first months of life.
Conclusions:
- Integrating passive (monoclonal antibodies) and active (vaccines) immunization is crucial for mitigating the public health impact of RSV.
- Combined immunization strategies can substantially decrease RSV-associated morbidity and mortality across diverse populations.
- Widespread implementation of these preventative measures is essential for global health.
More Related Videos
Related Concept Videos
Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation

